SCHEMBL9306554

SCHEMBL9306554

O=C1C(=NO)C(=NO)CCN1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.48
CRBN Q96SW2 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.44
DHPS P49366 2/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GRM5 P41594 1/20 0.43
MEN1 O00255 2/20 0.40
MAPK1 P28482 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9306550 1.00 DDB1 (0.48) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL9305095 0.87 DDB1 (0.49) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL9305088 0.87 DDB1 (0.49) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL4130800 0.82 ACHE (0.49) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL4130797 0.82 ACHE (0.49) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL20620191 0.76 ALDH1A1 (0.46) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL8248998 0.74 DDB1 (0.59) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL11052192 0.73 KMT2A (0.59) DDB1CRBNL3MBTL1KMT2APOLB
SCHEMBL9037778 0.72 DHPS (0.36) DDB1CRBNL3MBTL1DHPSKMT2A
SCHEMBL7837188 0.71 DDB1 (0.56) DDB1CRBNL3MBTL1DHPSKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5360812-A Fused 1,2,5-oxadiazole-2-oxides and their use CASSELLA AKTIENGESELLSCHAFT (DE) 1994-11-01 US disclosed
EP-0574726-A1 Annelated 1,2,5-oxadiozole-2 oxides and their use as pharmacological agents HOECHST AKTIENGESELLSCHAFT (DE) 1993-12-22 EP disclosed